Holen Sie sich die Stockscreener-App
52.53
0.83%
0.43
Handel nachbörslich:
52.53
Schlusskurs vom Vortag:
$52.10
Offen:
$51.9
24-Stunden-Volumen:
528.09K
Relative Volume:
1.12
Marktkapitalisierung:
$2.90B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$23.68M
KGV:
1,050.60
EPS:
0.05
Netto-Cashflow:
$108.67M
1W Leistung:
+1.39%
1M Leistung:
-1.94%
6M Leistung:
-15.22%
1J Leistung:
+12.32%
1-Tages-Spanne:
$51.87
$52.85
1-Wochen-Bereich:
$51.41
$55.32
52-Wochen-Spanne:
$42.75
$64.47
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Vergleichen Sie LIVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| LIVN | 52.53 | 2.90B | 1.24B | 23.68M | 108.67M | 0.05 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - Yahoo Finance
Cornercap Investment Counsel Inc. Sells 10,684 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Position Boosted by Victory Capital Management Inc. - MarketBeat
Entropy Technologies LP Buys Shares of 10,067 LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova (NASDAQ:LIVN) Downgraded to Buy Rating by StockNews.com - MarketBeat
State of New Jersey Common Pension Fund D Raises Stock Holdings in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences - Business Wire
Medical Implants Market Is Booming Worldwide 2024-2031 | Biotronik, Inc., Livanova Plc, NuVasive - openPR
LivaNova (NASDAQ:LIVN) Given Buy Rating at Needham & Company LLC - MarketBeat
LivaNova PLC (LIVN) SEC Filing Summary - Quartzy
Shareholders Will Be Pleased With The Quality of LivaNova's (NASDAQ:LIVN) Earnings - Yahoo Finance UK
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St
Vagus Nerve Stimulation (VNS) Market Market Size, Trends, - openPR
LivaNova announces OSPREY clinical study meets safety/efficacy endpoints - TipRanks
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - sharewise
LivaNova reports positive results in sleep apnea trial By Investing.com - Investing.com South Africa
LivaNova reports positive results in sleep apnea trial - Investing.com India
LivaNova plc (LIVN) Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - StreetInsider.com
Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
LivaNova (NASDAQ:LIVN) Upgraded by StockNews.com to Strong-Buy Rating - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
LivaNova (LIVN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
How Much Upside is Left in LivaNova (LIVN)? Wall Street Analysts Think 38.2% - Yahoo Finance
Chest Drainage Catheters Market Driven by Advancements in Medical Devices | LivaNova PLC, Mediplus, - EIN News
Oversold Conditions For LivaNova (LIVN) - Nasdaq
LivaNova (NASDAQ:LIVN) Trading Down 3.9%Should You Sell? - MarketBeat
LivaNova Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Nisa Investment Advisors LLC Lowers Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Is a LivaNova PLC (LIVN) Promising Medical Stock with Growth Potential? - Insider Monkey
Emerald Advisers LLC Purchases 14,302 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Simply Wall St
Earnings Beat: LivaNova PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Where are the Opportunities in (LIVN) - Stock Traders Daily
abrdn plc Purchases 70,618 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova maintains VNS Therapy classification By Investing.com - Investing.com Australia
LivaNova maintains VNS Therapy classification - Investing.com India
LivaNova price target raised to $72 from $66 at Baird - TipRanks
Mizuho Cuts LivaNova (NASDAQ:LIVN) Price Target to $70.00 - MarketBeat
LivaNova price target lowered to $70 from $80 at Mizuho - TipRanks
LivaNova (NASDAQ:LIVN) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Robert W. Baird Forecasts Strong Price Appreciation for LivaNova (NASDAQ:LIVN) Stock - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: LivaNova reports robust Q3 growth, raises 2024 outlook By Investing.com - Investing.com South Africa
Is Now An Opportune Moment To Examine LivaNova PLC (NASDAQ:LIVN)? - Yahoo Finance
Earnings call: LivaNova reports robust Q3 growth, raises 2024 outlook - Investing.com India
LivaNova PLC (LIVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance
LivaNova PLC (LIVN) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
LivaNova PLC Reports Strong Q3 2024 Results - TipRanks
LivaNova: Q3 Earnings Snapshot - Houston Chronicle
LivaNova PLC Q3 2024 Earnings: EPS of $0.60 Beats Estimates, Rev - GuruFocus.com
LivaNova beats Q3 expectations, raises 2024 guidance By Investing.com - Investing.com Nigeria
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):